Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04879745 · ClinicalTrials.gov registry record · NA
MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04879745 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 45 participants.
The verdict
NCT04879745, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care. • Hypothesis: MyVoice:Rheum will be feasible and acceptable to patients who receive rheumatology care.
Interventions
- OTHER Pamphlet
- OTHER MyVoice:Rheum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-07-29 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04879745
The ClinicalTrials.gov registry entry for NCT04879745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pamphlet is the first listed.
NCT04879745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04879745 about?
NCT04879745 is a clinical study titled "MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases". This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care. • Hypothesis: MyVoice:Rheum will be feasible and acceptable to patients who receive rheumatology care.
What is the current status of trial NCT04879745?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2021-07-29. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT04879745?
The interventions under investigation include: Pamphlet (OTHER), MyVoice:Rheum (OTHER).
Who is sponsoring clinical trial NCT04879745?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.